Evogene Ltd
NASDAQ:EVGN

Watchlist Manager
Evogene Ltd Logo
Evogene Ltd
NASDAQ:EVGN
Watchlist
Price: 1.13 USD 2.73%
Market Cap: 9.9m USD

Operating Margin
Evogene Ltd

-263.5%
Current
-744%
Average
-4.3%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-263.5%
=
Operating Profit
-13.6m
/
Revenue
5.2m

Operating Margin Across Competitors

No Stocks Found

Evogene Ltd
Glance View

Market Cap
9.8m USD
Industry
Biotechnology

Evogene Ltd. engages in the development and commercialization of a computer-biological platform for improving the development processes of products in the field of life sciences. Leveraging Big Data and Artificial Intelligence while incorporating a deep understanding of biology, Evogene established its technology, the Computational Predictive Biology (CPB) platform, to computationally design microbes, small molecules and genes as the core components for life-science products. Evogene holds a number of subsidiaries utilizing the CPB platform, for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits and ag-solutions for castor oil production.

EVGN Intrinsic Value
HIDDEN
Show
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-263.5%
=
Operating Profit
-13.6m
/
Revenue
5.2m
What is the Operating Margin of Evogene Ltd?

Based on Evogene Ltd's most recent financial statements, the company has Operating Margin of -263.5%.

Back to Top